Akynzeo 300 mg/0.5 mg
Akynzeo 300 mg/0.5 mg is a medicine authorised by Swissmedic under authorisation number 65499. The authorisation holder is Medius AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 06 November 2015 and the authorisation is valid without a time limit. ATC code A04AA55 places the medicine in the group Antiemetics and antinauseants.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Akynzeo 300 mg/0.5 mg, Kapseln | B | 06 November 2015 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Kapsel(n) | A04AA55 | 01.09.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Akynzeo 300 mg/0.5 mg authorised in Switzerland?
Yes. Akynzeo 300 mg/0.5 mg is authorised by Swissmedic under authorisation number 65499, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Akynzeo 300 mg/0.5 mg have?
Akynzeo 300 mg/0.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Akynzeo 300 mg/0.5 mg?
The authorisation holder is Medius AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.